Log In
BCIQ
Print this Print this
 

HibTITER (MT-2301, NU 300)

  Manage Alerts
Collapse Summary General Information
Company Nuron Biotech Inc.
DescriptionHaemophilus influenza type b vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationHaemophilus
Indication DetailsPrevent Haemophilus influenza type b infection
Regulatory Designation
PartnerMitsubishi Tanabe Pharma Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/23/2012

Undisclosed

Undisclosed

Undisclosed

04/06/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today